Furthermore, there were significant differences in the immune-checkpoint expressions (e.g., CTLA-4, PD-1, and TIM-3, Figure 2F) and HCC stage (Supplementary Figures S2A, B) among the three immune patterns, which were significantly correlated with tumor progression. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.